Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02707887 · ClinicalTrials.gov registry record · NA
Technology Enhanced Behavioral Activation Treatment for Substance Use
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 206
- Enrollment target
NCT02707887 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 206 participants.
The verdict
NCT02707887, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 206 participants
- Enrollment target
Study Summary
The purpose of this study is to: 1. test the effect of a smartphone enhanced LETS ACT (LETS ACT-SE) on frequency of substance use 2. use functional magnetic resonance imaging (fMRI) to test the relationship between neuromarkers of reward sensitivity on frequency of substance use.
Interventions
- BEHAVIORAL Treatment as Usual
- BEHAVIORAL LETS ACT
- BEHAVIORAL LETS ACT-SE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2016-01 |
| Est. Completion | 2020-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02707887
The ClinicalTrials.gov registry entry for NCT02707887 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Treatment as Usual is the first listed.
NCT02707887 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02707887 about?
NCT02707887 is a clinical study titled "Technology Enhanced Behavioral Activation Treatment for Substance Use". The purpose of this study is to: 1. test the effect of a smartphone enhanced LETS ACT (LETS ACT-SE) on frequency of substance use 2. use functional magnetic resonance imaging (fMRI) to test the relationship between neuromarkers of reward sensitivity on frequency of substance use.
What is the current status of trial NCT02707887?
This trial is currently completed. It is a NA study. The enrollment target is 206 participants. The study started on 2016-01. Estimated completion is 2020-12.
What interventions are being tested in trial NCT02707887?
The interventions under investigation include: Treatment as Usual (BEHAVIORAL), LETS ACT (BEHAVIORAL), LETS ACT-SE (BEHAVIORAL).
Who is sponsoring clinical trial NCT02707887?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.